Global Scleroderma Initiative

Global Scleroderma Initiative

Scleroderma Research Foundation

Scleroderma Research Foundation

Scleroderma Foundation

Scleroderma Foundation

Federation of European Scleroderma Associations (FESCA)

FESCA

Wednesday, December 23, 2015

FDA approves new orphan drug...

FDA approves new orphan drug to treat pulmonary arterial hypertension.




On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

Click here for more

Saturday, September 5, 2015

Scleroderma Society of Canada National Conference

Wednesday, July 22, 2015

Friday, July 3, 2015

Monday, June 29, 2015

WORLD SCLERODERMA DAY!

Thursday, June 4, 2015

June is Scleroderma Awareness Month

Friday, May 8, 2015

Meet e-Patient Dave

When Dave deBronkart learned he had a rare and terminal cancer, he turned to a group of fellow patients online — and found the medical treatment that saved his life. See it on TED: Meet e-Patient Dave

Thursday, May 7, 2015

Welcome!

Welcome to the newest guide to online Scleroderma resources..